Arena, J&J deal

JNJ's Ortho-McNeil Pharmaceutical Inc. unit extended for one year a 2004 deal with ARNA to develop compounds targeting the glucose-dependent insulinotropic (GDI) (19AJ) receptor to treat Type II dia...